ABSTRACT
A multifaceted approach was developed in the Suriname project to distribute benefits, including:
• a long-term research agreement that controls the ownership, licensing and royalty fee structure for any potential drug development;
• a statement of understanding that further defines the parties’ intentions regarding the distribution of royalties among Surinamese institutions;
• a trust document establishing the Forest People’s Fund (which is capitalized in part with upfront payments);
• provision for the transfer of technology and other forms of non-monetary compensation to the Suriname.
